Toshiba, under its new five-year business strategy, has developed a technology that uses microRNA molecules in the blood to detect cancer. The company has come up with a new technology that can detect 13 different types of cancer with 99 percent accuracy in less than 2 hours. Using a chip and a small device to conduct the diagnosis and it will cost $180 per test that can be used to efficiently detect different kinds of cancer cells.